Acute Myeloid Leukemia: Navigating Treatment Paradigm Shifts and Disease Heterogeneity
31:31
MRD in Acute Myeloid Leukemia
29:07
Newly diagnosed AML: Hitting the right target
1:00:50
Hodgkin's Lymphoma
22:25
Acute Myelogenous Leukemia AML: Transplant or Not?
43:57
Neurobiological mechanisms of ketamine's therapeutic effect [Prof Gerard Sanacora]
32:30
Strategies in Chronic Myeloid Leukemia: The Evolving Treatment Landscape
22:56
Measurable Residual Disease (MRD) in AML and ALL
40:09